Study identifies promising target for treating inflammatory bowel disease and colitis-induced colorectal cancers

by Will Cushman,University of Wisconsin-MadisonThis image shows the effect of pro-inflammatory cytokines on the growth of a mouse intestinal organoid. Intestinal stem cells (red) are indicative

Updated on: March 20,2024

Study identifies promising target for treating inflammatory bowel disease and colitis-induced colorectal cancers

by Will Cushman,University of Wisconsin-MadisonThis image shows the effect of pro-inflammatory cytokines on the growth of a mouse intestinal organoid. Intestinal stem cells (red) are indicative

Updated on:March 20,2024

Increased utilization of stereotactic body radiotherapy has decreased treatment disparities for early-stage NSCLC

by International Association for the Study of Lung CancerCredit: Unsplash/CC0 Public DomainThe use of Stereotactic Body Radiotherapy (SBRT) for patients with non-small cell lung cancer can reduce trea

Updated on: December 18,2023

Increased utilization of stereotactic body radiotherapy has decreased treatment disparities for early-stage NSCLC

by International Association for the Study of Lung CancerCredit: Unsplash/CC0 Public DomainThe use of Stereotactic Body Radiotherapy (SBRT) for patients with non-small cell lung cancer can reduce trea

Updated on:December 18,2023

Flu virus variants resistant to new antiviral drug candidate lose pathogenicity, study finds

by LaTina Emerson,Georgia State UniversityCredit: Pixabay/CC0 Public DomainInfluenza A viruses with induced resistance to a new candidate antiviral drug were found to be impaired in cell culture

Updated on: May 06,2024

Flu virus variants resistant to new antiviral drug candidate lose pathogenicity, study finds

by LaTina Emerson,Georgia State UniversityCredit: Pixabay/CC0 Public DomainInfluenza A viruses with induced resistance to a new candidate antiviral drug were found to be impaired in cell culture

Updated on:May 06,2024

Less chemotherapy better for older or frail patients with advanced stomach and oesophageal cancers

byCancer Research UK| News15 May 2019Less chemotherapy is as effective at controlling disease for elderly or frail patients with advanced cancer of the stomach or oesophagus (food pipe), a

Updated on: December 19,2023

Less chemotherapy better for older or frail patients with advanced stomach and oesophageal cancers

byCancer Research UK| News15 May 2019Less chemotherapy is as effective at controlling disease for elderly or frail patients with advanced cancer of the stomach or oesophagus (food pipe), a

Updated on:December 19,2023

Two cancer-causing genes work together to promote metastasis

byeLifeCredit: CC0 Public DomainCancer-promoting genes MYC and TWIST1 co-opt immune system cells to enable cancer cells to spread, but blocking a key step in this process can help prevent the di

Updated on: December 20,2023

Two cancer-causing genes work together to promote metastasis

byeLifeCredit: CC0 Public DomainCancer-promoting genes MYC and TWIST1 co-opt immune system cells to enable cancer cells to spread, but blocking a key step in this process can help prevent the di

Updated on:December 20,2023

Avoiding cloudy messaging: Vape prevention campaigns face challenges

by Flinders UniversityVaping prevention health communication campaign example materials: (A) NSW Health campaign media and toolkit, adapted, Bastion agency; (B) Lung Foundation Australia campaign

Updated on: March 25,2024

Avoiding cloudy messaging: Vape prevention campaigns face challenges

by Flinders UniversityVaping prevention health communication campaign example materials: (A) NSW Health campaign media and toolkit, adapted, Bastion agency; (B) Lung Foundation Australia campaign

Updated on:March 25,2024

FDA Approves Lymphir: A New Hope for CTCL Patients

The U.S. Food and Drug Administration (FDA) had approved Lymphir (denileukin diftitox-cxdl), a novel immunotherapy for the treatment of relapsed or refractory cutaneous T-cell lymphoma (CTCL) after at least one prior systemic therapy.

Updated on: August 12,2024

FDA Approves Lymphir: A New Hope for CTCL Patients

The U.S. Food and Drug Administration (FDA) had approved Lymphir (denileukin diftitox-cxdl), a novel immunotherapy for the treatment of relapsed or refractory cutaneous T-cell lymphoma (CTCL) after at least one prior systemic therapy.

Updated on:August 12,2024

What kind of support do breast cancer patients want? Food, rides and prayer

by Tisha Felder,The ConversationCredit: AI-generated imageFor 31 days every October, pink ribbons and #BCAM hashtags flood our social media timelines with information about breast cancer. That&#

Updated on: December 18,2023

What kind of support do breast cancer patients want? Food, rides and prayer

by Tisha Felder,The ConversationCredit: AI-generated imageFor 31 days every October, pink ribbons and #BCAM hashtags flood our social media timelines with information about breast cancer. That&#

Updated on:December 18,2023

Scientists discover key information about the function of mitochondria in cancer cells

byUniversity of California, Los AngelesCredit: Pixabay/CC0 Public DomainScientists have long known that mitochondria play a crucial role in the metabolism and energy production of cancer cells.

Updated on: December 27,2023

Scientists discover key information about the function of mitochondria in cancer cells

byUniversity of California, Los AngelesCredit: Pixabay/CC0 Public DomainScientists have long known that mitochondria play a crucial role in the metabolism and energy production of cancer cells.

Updated on:December 27,2023

Not all patients want faster cancer drug approvals without certainty they work

byLondon School of EconomicsCredit: Pixabay/CC0 Public DomainPatients with cancer could be willing to wait for greater certainty of the benefit of new cancer drugs before they are approved by th

Updated on: November 29,2024

Not all patients want faster cancer drug approvals without certainty they work

byLondon School of EconomicsCredit: Pixabay/CC0 Public DomainPatients with cancer could be willing to wait for greater certainty of the benefit of new cancer drugs before they are approved by th

Updated on:November 29,2024

Study points to novel method for early diagnosis of cachexia in lung cancer patients

by Ricardo Muniz,FAPESPCachexia classification models.ADecision tree generated using Classification And Regression Trees (CART). The bottom boxes indicate hazard ratios, the number o

Updated on: January 08,2024

Study points to novel method for early diagnosis of cachexia in lung cancer patients

by Ricardo Muniz,FAPESPCachexia classification models.ADecision tree generated using Classification And Regression Trees (CART). The bottom boxes indicate hazard ratios, the number o

Updated on:January 08,2024

Trial shows timing matters when adding immunotherapy to chemoradiation for limited-stage small cell lung cancer

byAmerican Society for Radiation OncologyCredit: Pixabay/CC0 Public DomainPeople with limited-stage small cell lung cancer may benefit from adding immunotherapy to chemoradiation, but not if bot

Updated on: October 26,2024

Trial shows timing matters when adding immunotherapy to chemoradiation for limited-stage small cell lung cancer

byAmerican Society for Radiation OncologyCredit: Pixabay/CC0 Public DomainPeople with limited-stage small cell lung cancer may benefit from adding immunotherapy to chemoradiation, but not if bot

Updated on:October 26,2024